Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Aug;39(2):330–333. doi: 10.1136/gut.39.2.330

RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

J M Ladero 1, J A Agúndez 1, A Rodríguez-Lescure 1, M Diaz-Rubio 1, J Benítez 1
PMCID: PMC1383320  PMID: 8977352

Abstract

BACKGROUND: CYP2E1, the coding gene for the ethanol inducible cytochrome P4502E1, is polymorphic at the RsaI restriction site in the 5' flanking region. The mutant allele c2 has a higher transcriptional activity than the wild-type gene c1. P4502E1 catalyses the activation of several environmental carcinogens at a rate that is increased, if only moderately, by longterm ethanol intake. AIMS: To establish the distribution of CYP2E1 RsaI polymorphism in patients with hepatocellular carcinoma and to evaluate its possible role in the multifactorial pathogenesis of this tumour. SUBJECTS: 101 (84 males) patients with hepatocellular carcinoma and 178 (128 males) healthy controls of the same ethnic (white) and Spanish origin. METHODS: After extraction of DNA from white blood cells, alleles c1 and c2 of CYP2E1 were identified by restriction fragment length polymorphism (RFLP) with endonuclease RsaI. RESULTS: Homozygous c1c1: 90 patients and 169 controls; heterozygous c1c2: 11 and 9; homozygous c2c2: none (non-significant difference). C2 allele frequencies: 0.055 in patients, 0.025 in controls (non-significant difference) and 0.108 in the 37 patients who had drunk more than 50 g of ethanol/day (p = 0.0035, odds ratio versus controls: 4.67; 95% confidence limits 1.57 to 13.81). CONCLUSION: The carrier state of one copy of the c2 CYP2E1 gene increases the risk of hepatoma in previously regular ethanol users with chronic liver disease.

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agúndez J. A., Ledesma M. C., Benítez J., Ladero J. M., Rodríguez-Lescure A., Díaz-Rubio E., Díaz-Rubio M. CYP2D6 genes and risk of liver cancer. Lancet. 1995 Apr 1;345(8953):830–831. doi: 10.1016/s0140-6736(95)92965-7. [DOI] [PubMed] [Google Scholar]
  2. Aoyama T., Yamano S., Guzelian P. S., Gelboin H. V., Gonzalez F. J. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4790–4793. doi: 10.1073/pnas.87.12.4790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Austin H., Delzell E., Grufferman S., Levine R., Morrison A. S., Stolley P. D., Cole P. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res. 1986 Feb;46(2):962–966. [PubMed] [Google Scholar]
  4. Carr L. G., Hartleroad J. Y., Liang Y., Mendenhall C., Moritz T., Thomasson H. Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol Clin Exp Res. 1995 Feb;19(1):182–184. doi: 10.1111/j.1530-0277.1995.tb01489.x. [DOI] [PubMed] [Google Scholar]
  5. Guengerich F. P., Kim D. H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991 Mar-Apr;4(2):168–179. doi: 10.1021/tx00020a008. [DOI] [PubMed] [Google Scholar]
  6. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991 Oct;110(4):559–565. doi: 10.1093/oxfordjournals.jbchem.a123619. [DOI] [PubMed] [Google Scholar]
  7. Hsing A. W., McLaughlin J. K., Hrubec Z., Blot W. J., Fraumeni J. F., Jr Cigarette smoking and liver cancer among US veterans. Cancer Causes Control. 1990 Nov;1(3):217–221. doi: 10.1007/BF00117473. [DOI] [PubMed] [Google Scholar]
  8. Ingelman-Sundberg M., Johansson I., Yin H., Terelius Y., Eliasson E., Clot P., Albano E. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol. 1993 Nov-Dec;10(6):447–452. doi: 10.1016/0741-8329(93)90063-t. [DOI] [PubMed] [Google Scholar]
  9. Kato S., Shields P. G., Caporaso N. E., Hoover R. N., Trump B. F., Sugimura H., Weston A., Harris C. C. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 1992 Dec 1;52(23):6712–6715. [PubMed] [Google Scholar]
  10. Kim R. B., O'Shea D., Wilkinson G. R. Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity. Pharmacogenetics. 1994 Jun;4(3):162–165. [PubMed] [Google Scholar]
  11. Liang T. J., Jeffers L. J., Reddy K. R., De Medina M., Parker I. T., Cheinquer H., Idrovo V., Rabassa A., Schiff E. R. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology. 1993 Dec;18(6):1326–1333. [PubMed] [Google Scholar]
  12. Lieber C. S. Alcohol and the liver: 1994 update. Gastroenterology. 1994 Apr;106(4):1085–1105. doi: 10.1016/0016-5085(94)90772-2. [DOI] [PubMed] [Google Scholar]
  13. Lieber C. S., Garro A., Leo M. A., Mak K. M., Worner T. Alcohol and cancer. Hepatology. 1986 Sep-Oct;6(5):1005–1019. doi: 10.1002/hep.1840060533. [DOI] [PubMed] [Google Scholar]
  14. Lucas D., Ménez C., Girre C., Berthou F., Bodénez P., Joannet I., Hispard E., Bardou L. G., Ménez J. F. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics. 1995 Oct;5(5):298–304. doi: 10.1097/00008571-199510000-00005. [DOI] [PubMed] [Google Scholar]
  15. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 1986 Aug;73(4):320–326. doi: 10.1007/BF00279094. [DOI] [PubMed] [Google Scholar]
  16. Ono S., Hatanaka T., Hotta H., Tsutsui M., Satoh T., Gonzalez F. J. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics. 1995 Jun;5(3):143–150. doi: 10.1097/00008571-199506000-00002. [DOI] [PubMed] [Google Scholar]
  17. Pequignot G., Tuyns A. J., Berta J. L. Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol. 1978 Jun;7(2):113–120. doi: 10.1093/ije/7.2.113. [DOI] [PubMed] [Google Scholar]
  18. Perrot N., Nalpas B., Yang C. S., Beaune P. H. Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake. Eur J Clin Invest. 1989 Dec;19(6):549–555. doi: 10.1111/j.1365-2362.1989.tb00273.x. [DOI] [PubMed] [Google Scholar]
  19. Persson I., Johansson I., Bergling H., Dahl M. L., Seidegård J., Rylander R., Rannug A., Högberg J., Sundberg M. I. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett. 1993 Mar 22;319(3):207–211. doi: 10.1016/0014-5793(93)80547-8. [DOI] [PubMed] [Google Scholar]
  20. Ruiz J., Sangro B., Cuende J. I., Beloqui O., Riezu-Boj J. I., Herrero J. I., Prieto J. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 1992 Sep;16(3):637–641. doi: 10.1002/hep.1840160305. [DOI] [PubMed] [Google Scholar]
  21. Sherlock S. Alcoholic liver disease. Lancet. 1995 Jan 28;345(8944):227–229. doi: 10.1016/s0140-6736(95)90226-0. [DOI] [PubMed] [Google Scholar]
  22. Stephens E. A., Taylor J. A., Kaplan N., Yang C. H., Hsieh L. L., Lucier G. W., Bell D. A. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics. 1994 Aug;4(4):185–192. doi: 10.1097/00008571-199408000-00002. [DOI] [PubMed] [Google Scholar]
  23. Takahashi T., Lasker J. M., Rosman A. S., Lieber C. S. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology. 1993 Feb;17(2):236–245. [PubMed] [Google Scholar]
  24. Takahashi T., Lasker J. M., Rosman A. S., Lieber C. S. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology. 1993 Feb;17(2):236–245. [PubMed] [Google Scholar]
  25. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver. 1994 Apr;14(2):98–102. doi: 10.1111/j.1600-0676.1994.tb00055.x. [DOI] [PubMed] [Google Scholar]
  26. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993 Jun 24;328(25):1797–1801. doi: 10.1056/NEJM199306243282501. [DOI] [PubMed] [Google Scholar]
  27. Tsutsumi M., Lasker J. M., Shimizu M., Rosman A. S., Lieber C. S. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology. 1989 Oct;10(4):437–446. doi: 10.1002/hep.1840100407. [DOI] [PubMed] [Google Scholar]
  28. Tsutsumi M., Matsuda Y., Takada A. Role of ethanol-inducible cytochrome P-450 2E1 in the development of hepatocellular carcinoma by the chemical carcinogen, N-nitrosodimethylamine. Hepatology. 1993 Dec;18(6):1483–1489. [PubMed] [Google Scholar]
  29. Yang C. S., Yoo J. S., Ishizaki H., Hong J. Y. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev. 1990;22(2-3):147–159. doi: 10.3109/03602539009041082. [DOI] [PubMed] [Google Scholar]
  30. Yang C. S., Yoo J. S., Ishizaki H., Hong J. Y. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev. 1990;22(2-3):147–159. doi: 10.3109/03602539009041082. [DOI] [PubMed] [Google Scholar]
  31. Yu M. W., Gladek-Yarborough A., Chiamprasert S., Santella R. M., Liaw Y. F., Chen C. J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology. 1995 Oct;109(4):1266–1273. doi: 10.1016/0016-5085(95)90587-1. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES